Epigenomics Studies in Acute Myeloid Leukemia (AML)
Demographics (2)
- Age - Age at time of sample collection (phv00258411.v3.p1)
- SEX - Sex of participant (phv00489913.v2.p1)
Disease Events (1)
- AFFECTION_STATUS - Case versus control samples. Cases are patients diagnosed with non-M3 Acute Myeloid Leukemia (AML), who received induction chemotherapy treatment with combination chemotherapy including, but not limited to an anthracycline and cytosine arabinoside, and patients from whom specimens with high blast cell percentages were available from diagnosis and relapse time points. Controls are age-matched individuals and without any known hematological conditions with CD34+ cell enrichment greater than 90%. (phv00489914.v2.p1)
Other (26)
- ANALYTE_TYPE - Analyte Type (phv00258421.v3.p1)
- BODY_SITE - Body site where sample was collected (phv00258420.v3.p1)
- CONSENT - Consent group as determined by DAC (phv00258401.v3.p1)
- Cytogenetics - Cytogenetics results (phv00258414.v3.p1)
- Disease_stage - Disease state at the time of sample collection or germline specimen collection (phv00258412.v3.p1)
- FAB - French American British disease classification: MLD = multi-lineage dysplasia, RAEB-t = refractory anemia with excess blasts in transformation (phv00258416.v3.p1)
- GEO_ACCESSION - GEO accession ID (phv00265702.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00258423.v3.p1)
- IS_TUMOR - Tumor status (phv00258422.v3.p1)
- mutGenes - Clinically-annotated mutant genes: NPM1 nucleophosmin, FLT3-ITD Fms-like tyrosine kinase 3 internal tandem duplication, FLT3-TKD Fms-like tyrosine kinase 3 tyrosine kinase domain, CEBPA CCAAT enhancer binding protein alpha (phv00258415.v3.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor (Primary) or not applicable (N/A) (phv00258424.v3.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00258425.v3.p1)
- SAMPLE_ID - De-identified Sample ID (phv00258419.v3.p1)
- SAMPLE_ID - Sample ID (phv00258406.v3.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing/source of raw data (phv00258427.v3.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00258403.v3.p1)
- SUBJECT_ID - De-identified Subject ID (phv00258410.v3.p1)
- SUBJECT_ID - Subject ID (phv00258400.v3.p1)
- SUBJECT_ID - Subject ID (phv00258405.v3.p1)
- SUBJECT_ID - Subject ID (phv00265701.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00258402.v3.p1)
- TTR - Time to relapse (phv00258418.v3.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00258957.v3.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00258956.v3.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00258426.v3.p1)
- WBC - Peripheral blood white blood cell count (phv00258417.v3.p1)